Please login to the form below
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew
Three steps forward, four steps back
How to ensure digital content achieves the right dialogue
Real-world studies
by Bill Row
Is it time for a more integrated and human-centric approach to Medical Affairs leadership?
By Shairose Ebrahim
Rare disease trials Q&A
By Gretchen Goller and Valerie Legrand
-
Lonely planet: why there is dwindling value in pharma travelling aloneTo develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward
-
Accelerating diagnosis in rare diseaseBiopharmaceutical companies can drive effective partnerships and improve outcomes for all stakeholders and patients in the area of rare disease.
-
Accelerating innovationIpsen’s Alexandre Lebeaut on the French firm’s oncology plans, global focus and R&D approach
-
Janssen’s quest to prevent diseases taking holdJohan van Hoof, general manager of Janssen Vaccines & Prevention, on 'recalibrating' public understanding of illness
-
Opening up innovationPaul-Peter Tak on GlaxoSmithKline’s R&D strategy and the pivotal role of immunology
-
Transformational technologyBig data, the cloud and the value of insights
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Senior Medical Writer
-
Salary TBC
-
Account Executive
-
Salary TBC
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
-
Account Supervisor
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
-
Account Director
-
Salary TBC
Subscribe to our email news alerts
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- Nucala works in rare inflammatory disease, says GSK
- Otsuka presses on with Alzheimer’s agitation drug
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- The first of many celebrations for Lucid Group at Middlesex House
- Antibiotic resistance: The silent pandemic
- BMS, Celgene merger should close this week after FTC okay
- The NHS is facing shortages of lifesaving treatments, says internal document
- Happy 2nd birthday to Porterhouse Medical US
- Roche agrees $1.4bn takeover of fibrosis specialist Promedior
- Novartis’ Mayzent and Roche’s Polivy lead CHMP recommendations
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- RWE Blog 3: Is real-world evidence the holy grail
- We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
- Strengthening business competition and reducing anti-competitive practices
- How the CMA is tackling high prices for essential drugs...
Quick links
Infographics
